Author

Agnès Coste

Primary ORCID profile (0000-0001-7781-3323 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Agnès CosteiD2 papers · Centre National de la Recherche Scientifique

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Alejandra Martinez· 1 shared Augustin Le Naour· 1 shared Benoit Thibault· 1 shared Bettina CouderciD· 1 shared Eliane Mery· 1 shared Gwenael Ferron· 1 shared Helene Leray· 1 shared Jean-Pierre Delord· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alejandra Martinez

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintDec 4, 2018

Mesenchymal stromal cells release CXCL1/2/8 and induce chemoresistance and macrophage polarization

Bettina Couderc, Augustin Le Naour, Mélissa Prat…·Agnès Coste

This study identifies CXCL1/2/8 as factors released by cancer-associated mesenchymal stromal cells that induce chemoresistance and macrophage polarization, suggesting CXCR1/2 inhibition as a potential therapeutic strategy.

DOI 10.1101/482513

humanbulk RNA-seq

𝕏 PostBluesky